131 related articles for article (PubMed ID: 22722057)
1. The overuse of intensity-modulated radiotherapy and the role of the healthcare payer.
Loblaw DA
Clin Oncol (R Coll Radiol); 2012 Sep; 24(7):459-60. PubMed ID: 22722057
[No Abstract] [Full Text] [Related]
2. Medical memo: high-dose radiotherapy for prostate cancer.
Harv Mens Health Watch; 2007 Apr; 11(9):6. PubMed ID: 17441270
[No Abstract] [Full Text] [Related]
3. A practical approach to diode based in vivo dosimetry for intensity modulated radiotherapy.
Kadesjö N; Nyholm T; Olofsson J
Radiother Oncol; 2011 Mar; 98(3):378-81. PubMed ID: 21295879
[TBL] [Abstract][Full Text] [Related]
4. Future issues in highly conformal radiotherapy for head and neck cancer.
Feng M; Eisbruch A
J Clin Oncol; 2007 Mar; 25(8):1009-13. PubMed ID: 17350951
[TBL] [Abstract][Full Text] [Related]
5. Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001).
Ost P; Fonteyne V; De Neve W; De Gersem W; De Wagter C; Vandecasteele K; Duprez F; De Meerleer G
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1286; author reply 1287. PubMed ID: 19251105
[No Abstract] [Full Text] [Related]
6. Cost-effectiveness of intensity-modulated radiotherapy in prostate cancer.
Yong JH; Beca J; McGowan T; Bremner KE; Warde P; Hoch JS
Clin Oncol (R Coll Radiol); 2012 Sep; 24(7):521-31. PubMed ID: 22705100
[TBL] [Abstract][Full Text] [Related]
7. Intensity modulated radiation therapy.
Maddock PG
Med Health R I; 2006 Feb; 89(2):76-8. PubMed ID: 16583667
[No Abstract] [Full Text] [Related]
8. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.
Lips I; Dehnad H; Kruger AB; van Moorselaar J; van der Heide U; Battermann J; van Vulpen M
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):656-61. PubMed ID: 17512127
[TBL] [Abstract][Full Text] [Related]
9. Dose painting: art or science?
Tanderup K; Olsen DR; Grau C
Radiother Oncol; 2006 Jun; 79(3):245-8. PubMed ID: 16725221
[No Abstract] [Full Text] [Related]
10. Intensity-modulated radiation therapy and xerostomia.
Chambers MS; Weber RS; Garden AS
J Calif Dent Assoc; 2006 Sep; 34(9):743-8. PubMed ID: 17022299
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary results of the assessment of intensity modulated radiotherapy (IMRT) for prostatic and head and neck tumors (STIC 2001)].
Marchal C; Lapeyre M; Beckendorf V; Aletti P; Haslé E; Dubois JB; Maingon P; Bensadoun RJ; Le Prise E; Lartigau E; Carrie C; Dubray B; Marchesi V; Ailleres N; Naudy S; Marcie S; Manens JP; Mazurier J; Ginestet C; Chauvin F; Pommier P; Gerard JP; Carrere MO
Cancer Radiother; 2004 Nov; 8 Suppl 1():S121-7. PubMed ID: 15679257
[TBL] [Abstract][Full Text] [Related]
12. [Intensity Modulated Radiation Therapy (IMRT)].
Maebayashi K; Nasu S; Seki K; Kiyoduka M; Hashimoto Y; Mitsuhashi N
Gan To Kagaku Ryoho; 2006 Apr; 33(4):436-43. PubMed ID: 16612150
[TBL] [Abstract][Full Text] [Related]
13. A marginal issue: in regard to Wolden et al. (Int J Radiat Oncol Biol Phys 2005;61:1432-1438).
Scarbrough TJ; Thomas CR
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):647-8; author reply 648-9. PubMed ID: 16168860
[No Abstract] [Full Text] [Related]
14. Dynamic intensity-modulated non-coplanar arc radiotherapy (INCA) for head and neck cancer.
Krayenbuehl J; Davis JB; Ciernik IF
Radiother Oncol; 2006 Nov; 81(2):151-7. PubMed ID: 17055095
[TBL] [Abstract][Full Text] [Related]
15. [Intensity-modulated radiation therapy (IMRT)].
Nakamura N; Shikama N; Oguchi M
Nihon Rinsho; 2010 Jun; 68(6):1035-9. PubMed ID: 20535952
[TBL] [Abstract][Full Text] [Related]
16. Certificate of need programs, intensity modulated radiation therapy use and the cost of prostate cancer care.
Khanna A; Hu JC; Gu X; Nguyen PL; Lipsitz S; Palapattu GS
J Urol; 2013 Jan; 189(1):75-9. PubMed ID: 23164382
[TBL] [Abstract][Full Text] [Related]
17. [Prostate cancer].
Vieillot S; Fenoglietto P; Aillères N; Hay MH; Dubois JB; Azria D
Cancer Radiother; 2010 Nov; 14 Suppl 1():S161-73. PubMed ID: 21129660
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer.
Sharma NK; Li T; Chen DY; Pollack A; Horwitz EM; Buyyounouski MK
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):437-44. PubMed ID: 21050673
[TBL] [Abstract][Full Text] [Related]
19. Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis.
Sher DJ; Neville BA; Chen AB; Schrag D
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e197-206. PubMed ID: 21596483
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of dual-arc VMAT radiotherapy treatment plans automatically generated via dose mimicking.
Petersson K; Nilsson P; Engström P; Knöös T; Ceberg C
Acta Oncol; 2016; 55(4):523-5. PubMed ID: 26361238
[No Abstract] [Full Text] [Related]
[Next] [New Search]